Low thromboembolic risk without anticoagulation using advanced-design left ventricular assist devices

Annals of Thoracic Surgery

Volumn 62, Issue 5, 1996, Pages 1321-1328

  Slater, James P ^b   Rose, Eric A ^b   Levin, Howard R ^b   Frazier, O H ^b   Roberts, J Kirk ^b   Weinberg, Alan D ^b   Oz, Mehmet C ^a  

^a New York Presbyterian Hospital Columbia University Medical Center   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ANTICOAGULATION; ARTICLE; ASSISTED CIRCULATION; FEMALE; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; THROMBOEMBOLISM;

EID: 0000576204     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/0003-4975(96)00750-3     Document Type: Article

References (41)

1. 1. United Network for Organ Sharing (UNOS). UNOS Update 1993;9:25.
2. 2. Miller LW, Kubo SH, Young JB, Stevenson LW, Loh E, Costanzo MR. Report of the consensus conference on candidate selection for heart transplantation - 1993. J Heart Lung Transplant 1995;14:562-71.
3. 3. McCarthy PM, Portner PM, Tobler CH, Starnes VA, Ramasamy N, Oyer PE. Clinical experience with the Novacor ventricular assist system. Bridge to transplantation and the transition to permanent application. J Thorac Cardiovasc Surg 1991;102:578-87.
4. 4. Frazier OH, Rose EA, Macmanus Q, et al. Multicenter clinical experience with the HeartMate 1000 IP LVAD. Ann Thorac Surg 1992;53:1080-90.
5. 5. Burton NA, Lefrak EA, Macmanus Q, et al. A reliable bridge to cardiac transplantation: the TCI left ventricular assist device. Ann Thorac Surg 1993;55:1425-30.
6. 6. Pennington DG, McBride LR, Peigh PS, Miller LW, Swartz MT. Eight years experience with bridging to cardiac transplantation. J Thorac Cardiovasc Surg 1994;107:472-80.
7. 7. McCarthy PM. HeartMate implantable left ventricular assist device:bridge to transplantation and future applications. Ann Thorac Surg 1995;59(Suppl):S46-51.
8. 8. Dasse KA, Frazier OH, Macoviak J, Menconi M, Poirier VL. Textured blood contacting surfaces for heart assist systems: current clinical experience. Proc Soc Biomater 1989:36.
9. 9. Icenogle TB, Smith RG, Cleavinger M, et al. Thromboembolic complications of the Symbion AVAD system. Artif Organs 1989;13 532-538.
10. 10. Levinson MM, Smith RG, Cork RC, et al. Thromboembolic complications of the Jarvik-7 total artificial heart: case report. Artif Organs 1989;10:236-44.
11. 11. Didisheim P, Olsen DB, Fara DJ, et al. Infection and thromboembolism with implantable cardiovascular devices. Trans Am Soc Artif Intern Organs 1987;33:418-25.
12. 12. Wagner WR, Johnson PC, Kormos RL, Griffith P. Evaluation of bioprosthetic valve-associated thrombus in ventricular assist device patients. Circulation 1993;88:2023-9.
13. 13. Rose EA, Levin HR, Oz MC, et al. Artificial circulatory support with textured interior surfaces. A counterintuitive approach to minimizing thromboembolism. Circulation 1994;90(Suppl 2):87-91.
14. 14. Edmunds LH Jr. Thromboembolic complications of current cardiac valvular prostheses. Ann Thorac Surg 1982;34:96-106.
15. 15. Consensus committee of the ninth international cerebral hemodynamic symposium. Basic identification criteria of Doppler microembolic signals. Stroke 1995;26:1123.
16. 16. Oz MC, Rose EA, Levin HR. Selection criteria for ventricular assist device placement. Am Heart J 1995;129:173-7.
17. 17. Kormos RL, Murali S, Dew MA, et al. Chronic mechanical circulatory support: rehabilitation, low morbidity, and superior survival. Ann Thorac Surg 1994;57:51-8.
18. 18. Farrar DJ, Hill D. Univentricular and biventricular Thoratec VAD support as a bridge to transplantation. Ann Thorac Surg 1993;55:276-82.
19. 19. Johnson KE, Prieto M, Joyce LD, Pritzker M, Emery RW. Summary of the clinical use of the Symbion total artificial heart: a registry report. J Heart Lung Transplant 1992;11: 103-16.
20. 20. Addonizio VP. Platelet function in cardiopulmonary bypass and artificial organs. Hematol Oncol Clin North Am 1990;4: 145-55.
21. 21. EPSIM Research Group. A controlled comparison of aspirin and oral anticoagulants in prevention of death after myocardial infarction. N Engl J Med 1982;307:701-8.
22. 22. Roberts WC, Siegel RJ, McManus BM. Idiopathic dilated cardiomyopathy: analysis of 152 necropsy patients. Am J Cardiol 1987;60:1340-55.
23. 23. Schober R, Herman MM. Neuropathology of cardiac transplantation: survey of 31 cases. Lancet 1973;1:962-7.
24. 24. Riess, Schminke U, Daffertshofer M, Schindlmayr C, Hennerici M. High intensity transient signals and carotid artery disease. Cerebrovasc Dis 1995;5:124-7.
25. 25. Siebler M, Kleinschmidt A, Sitzer M, Freund HJ. Cerebral microembolism in symptomatic and asymptomatic highgrade internal artery stenosis. Neurology 1994;44:615-7.
26. 26. Ackerstaff RGA, Jansen C, Moll FL, Vermeulen FEE, Hamerlijnck RPHM, Mauser HW. The significance of microemboli detection by means of transcranial Doppler ultrasonography monitoring in carotid endarterectomy. J Vasc Surg 1995;21: 963-9.
27. 27. Clark RE, Brillman J, Davis DA, Lovell MR, Price TR, Magovern GJ. Microemboli during coronary artery bypass grafting. J Thorac Cardiovasc Surg 1995;109:249-58.
28. 28. Georgiadis D, Grosset DG, Kelman A, Faichney A, Lees KR. Prevalence and characteristics of intercranial microemboli signals in patients with different types of prosthetic cardiac valves. Stroke 1994;25:587-92.
29. 29. Sliwaka U, Job FP, Wissura D, et al. Occurrence of transcranial Doppler high-intensity transient signals in patients with potential cardiac sources of embolism. Stroke 1995;26: 2067-70.
30. 30. Levin HR, Mohr JP, Chen JM, Oz MC, Trocia S, Rose EA. Thromboembolism in patients with textured surface LVAD's: a case control transcranial Doppler study. J Heart Lung Transplant 1994;13:s37.
31. 31. Nabavi DG, Geordiadis D, Mumme T, et al. Detection of microemboli signals in patients with LVAD. J Neuroimag 1995;5(Suppl 2):s67.
32. 32. Knepper LE, Eidelman BH, Thompson J, Kormos RL. Transcranial Doppler monitoring of patients with left ventricular assist devices [Abstract]. Stroke 1993;24:509.
33. 33. Dasse KA, Chipman SD, Sherman CN, Levine AH, Frazier OH. Clinical experience with textured blood contacting surfaces in ventricular assist devices. Trans Am Soc Artif Organs 1987;33:418-25.
34. 34. Graham TR, Dasse K, Cournbe A, et al. Neo-intimal development on textured biomaterial surfaces during clinical use of an implantable left ventricular assist device. Eur J Cardiothorac Surg 1990;4:182-90.
35. 35. Salih V, Graham TR, Berry CL, et al. The lining of textured surfaces in implantable left ventricular assist devices. An immunocytochemical and electronmicroscopic study. Am J Cardiovasc Pathol 1993;4:317-25.
36. 36. Markus HS. Experimental embolic events. Cerebrovasc Dis 1995;5:117-20.
37. 37. Nakatani T, Noda H, Beppu S, et al. Thrombus in a natural left ventricle during left ventricular assist: another thromboembolic risk factor. ASAIO Trans 1990;36:M711-4.
38. 38. Rafii S, Oz MC, Seldomridge JA, et al. Characterization of hematopoietic cells arising on the textured surface of left ventricular assist devices. Ann Thorac Surg 1995;60:1627-32.
39. 39. Menconi MJ, Pockwinse S, Owen TA, Dasse KA, Stein GS, Lian JB. Properties of blood-contacting surfaces of clinically implanted cardiac assist devices: gene expression, matrix composition, and ultrastructural characterization of cellular linings. J Cell Biochem 1995;57:557-73.
40. 40. Menconi MJ, Owen T, Dasse KA, Stein G, Lian JB. Molecular approaches to the characterization of cell and blood/biomaterial interactions. J Cardiac Surg 1992;7:177-87.
41. 41. Levin HR, Oz MC, Burkhoff D, et al. Can left ventricular assist devices be used as outpatient therapy while awaiting transplant? Assessment of long-term hemodynamics and functional capacity. Ann Thorac Surg 1994;58:1515-20.